Earnings Preview For Verona Pharma
Portfolio Pulse from Benzinga Insights
Verona Pharma (NASDAQ:VRNA) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with an expected EPS of $-0.26. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows a mixed reaction to past earnings reports, with the stock price fluctuating based on the actual EPS compared to estimates. Currently, VRNA shares are trading at $17.91, marking a 20.21% decrease over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.
February 28, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Verona Pharma is expected to report an EPS of $-0.26 for the upcoming quarter. Historical performance shows a positive stock price reaction to earnings beats. Currently, the stock is down 20.21% over the last year, indicating bearish sentiment.
Given VRNA's history of positive stock price reactions to earnings beats and the current bearish sentiment, a beat on the expected EPS of $-0.26 could lead to a short-term positive impact on the stock price. However, the overall bearish trend and the 20.21% decrease over the last year suggest that any positive movement might be moderate unless accompanied by strong forward guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100